Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
International Journal of Pharmaceutical and Healthcare Marketing is Scopus-indexed (Q3, CiteScore 2.8), ABDC C, ABS / AJG 1, WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Emerald Group Publishing.
Checked against the index lists dated .
ISSN 1750-6123Verify ISSN ↗1750-6131Verify ISSN ↗
Publisher: Emerald Group Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Health Policy | 175 / 330 | 46th | Q3 |
| Marketing | 138 / 221 | 37th | Q3 |
Not listed in: DOAJ, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q3, CiteScore 2.8.
International Journal of Pharmaceutical and Healthcare Marketing is Q3 in Health Policy (rank 175 of 330) and Q3 in Marketing (rank 138 of 221), by CiteScore 2025.
International Journal of Pharmaceutical and Healthcare Marketing is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.8, which places it in quartile Q3 at the 46th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.287, quartile Q3, with an H-index of 33.
International Journal of Pharmaceutical and Healthcare Marketing is published by Emerald Group Publishing. Its print ISSN is 1750-6123 and its online ISSN is 1750-6131.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
It is rated C in the ABDC Journal Quality List 2025 under Marketing.
It is graded 1 in the Chartered Association of Business Schools (ABS) Academic Journal Guide (AJG) 2024, in the Marketing field.
No — it is not registered as an open-access journal in DOAJ or Scopus.
International Journal of Pharmaceutical and Healthcare Marketing has an h-index of 42 and a 2-year mean of 1.91 citations per paper (OpenAlex). Its Scopus CiteScore is 2.8, quartile Q3. On 2-year citations it ranks #120 of 327 Scopus journals in Health Policy.
International Journal of Pharmaceutical and Healthcare Marketing published 85 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from India (30%), Indonesia (7.5%) and Brazil (6.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.5 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.